The established fundamental credit research capabilities backing Fidelity Corporate Bond, which includes a mutual fund and exchange-traded fund, inspire confidence, but the strategy still has more to prove.
Fidelity Advisor Corporate Bond Fund - Class A FCBAX
- NAV / 1-Day Return 10.53 / 0.00
- Total Assets 2.0B
-
Adj. Expense Ratio
0.770%
- Expense Ratio 0.770%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Corporate Bond
- Credit Quality / Interest Rate Sensitivity Medium/Moderate
- Min. Initial Investment 0
- Status Open
- TTM Yield 3.95%
- Effective Duration 6.54 years
USD | NAV as of Jul 17, 2026 | 1-Day Return as of Jul 17, 2026, 4:50 AM GMT+0
Morningstar’s Analysis FCBAX
Will FCBAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 7.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Fidelity Cash Central Fund | 2.07 | 42M | Cash and Equivalents |
United States Treasury Bonds 4.75% | 1.96 | 40M | Government |
Peachtree Corners Funding Trust 6.012% | 0.65 | 13M | Corporate |
Bayer US Finance LLC 6.875% | 0.61 | 12M | Corporate |
Morgan Stanley 5.32% | 0.60 | 12M | Corporate |
JPMorgan Chase & Co. 5.717% | 0.60 | 12M | Corporate |
Wells Fargo & Co. 5.499% | 0.58 | 12M | Corporate |
Hudson Pacific Properties LP 5.95% | 0.53 | 11M | Corporate |
Ares Capital Corp. 2.15% | 0.53 | 11M | Cash and Equivalents |
Omega Healthcare Investors, Inc. 3.375% | 0.52 | 11M | Corporate |